Qualitative study to characterize patient experience and relevance of patient-reported outcome measures for patients with metastatic synovial sarcoma
Eliason, Laurie, Grant, Laura, Francis, Anya, Cardellino, Anna, Culver, Ken, Chawla, Sant P., Arbuckle, Rob, Pokras, Shibani
Published in Journal of patient-reported outcomes (04.05.2022)
Published in Journal of patient-reported outcomes (04.05.2022)
Get full text
Journal Article
P905: PATIENT REPORTED OUTCOMES IN TRIPLE CLASS EXPOSED, RELAPSED/REFRACTORY MULTIPLE MYELOMA (TCE RRMM) PATIENTS IN KARMMA 3 TRIAL (PHASE 3 RCT): IDECABTAGENE VICLEUCEL (IDE‐CEL) VERSUS STANDARD REGIMENS
Delforge, Michel, Patel, Krina, Eliason, Laurie, Dhanda, Devender, Shi, Ling, Guo, Shien, Marshall, Thomas, Arnulf, Bertrand, Cavo, Michele, Nooka, Ajay, Manier, Salomon, Callander, Natalie, Giralt, Sergio, Einsele, Hermann, Ailawadhi, Sikander, Popa Mckiver, Mihaela, Cook, Mark, Rodríguez‐Otero, Paula
Published in HemaSphere (08.08.2023)
Published in HemaSphere (08.08.2023)
Get full text
Journal Article
Patient-Reported Outcomes With Belantamab Mafodotin Treatment in Patients With Triple-Class Refractory Multiple Myeloma
Popat, BSc, MBBS, MRCP, FRCPath, PhD, Rakesh, Lonial, MD, FACP, Sagar, M. Voorhees, MD, Peter, Degli Esposti, MD, Simona, Gorsh, PharmD, Boris, Gupta, MD, Ira, Opalinska, PhD, Joanna, Sapra, PhD, Sandhya, Piontek, BS, RN, Trisha, He, PhD, Zangdong, Kleinman, MD, MBA, David, Schaumberg, SCD, OD, MPH, Debra, Regnault, PhD, Antoine, Meunier, MSc, Juliette, Eliason, MPH, Laurie
Published in Journal of the advanced practitioner in oncology (01.09.2023)
Published in Journal of the advanced practitioner in oncology (01.09.2023)
Get full text
Journal Article
A toolbox of different approaches to analyze and present PRO-CTCAE data in oncology studies
Regnault, Antoine, Loubert, Angély, Gorsh, Boris, Davis, Randy, Cardellino, Anna, Creel, Kristin, Quéré, Stéphane, Sapra, Sandhya, Nelsen, Linda, Eliason, Laurie
Published in JNCI : Journal of the National Cancer Institute (08.05.2023)
Published in JNCI : Journal of the National Cancer Institute (08.05.2023)
Get full text
Journal Article
Patient-Reported Outcomes from the MCL Cohort of the Phase 1, Seamless Design TRANSCEND NHL 001 Study of Lisocabtagene Maraleucel in Patients with R/R B-Cell NHL
Wang, Michael L., Gordon, Leo I., Hirayama, Alexandre V, Lunning, Matthew A, Shi, Ling, Guo, Shien, Kostic, Ana, Eliason, Laurie, Kumar, Jinender, Palomba, Maria Lia
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Patient-Reported Outcomes (PROs) from the Phase 2 TRANSCEND FL Study of Lisocabtagene Maraleucel (liso-cel) in Patients (pts) with Relapsed or Refractory Follicular Lymphoma (FL)
Cartron, Guillaume, Martin Garcia-Sancho, Alejandro, Reguera, Juan Luis, Dahiya, Saurabh, Guo, Shien, Shi, Ling, Eliason, Laurie, Kumar, Jinender, Farazi, Thalia, Fasan, Omotayo, Izutsu, Koji
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Patient (pt) Experiences of Receiving Idecabtagene Vicleucel (Ide-Cel, bb2121) Versus Standard (Std) Regimens for the Treatment (Tx) of Relapsed/Refractory Multiple Myeloma (RRMM) in the Randomized, Controlled KarMMa-3 Clinical Trial: Analysis of Longitudinal Qualitative Interviews
Rodríguez Otero, Paula, Patel, Krina K., Raje, Noopur S., Moshkovich, Olga, Gerould, Heather, Devlen, Jennifer, Dhanda, Devender, Eliason, Laurie, Cook, Mark, Popa-McKiver, Mihaela, Manier, Salomon
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Patient-reported outcomes (PRO) in patients (pts) with advanced or recurrent dMMR/MSI-H endometrial cancer (EC) treated with dostarlimab in the GARNET trial
Kristeleit, Rebecca Sophie, Mathews, Cara Amanda, Redondo, Andrés, Huang, Joice, Eliason, Laurie, Im, Ellie, Brown, Jubilee
Published in Journal of clinical oncology (10.10.2020)
Published in Journal of clinical oncology (10.10.2020)
Get full text
Journal Article
DREAMM-1 Patient perspectives from the first-in-human study of single-agent belantamab mafodotin for relapsed and refractory multiple myeloma (RRMM)
Eliason, Laurie, Opalinska, Joanna, Martin, Mona L., Correll, Julia, Gutierrez, Benjamin, Popat, Rakesh
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Patient-reported outcomes (PRO) in the GARNET trial in patients (pts) with advanced or recurrent dMMR/MSI-H endometrial cancer (EC) treated with dostarlimab
Kristeleit, Rebecca Sophie, Mathews, Cara Amanda, Redondo, Andres, Huang, Joice, Eliason, Laurie, Im, Ellie, Brown, Jubilee
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Landscape review of the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) in oncology: Adoption and recent learnings
Regnault, Antoine, Quéré, Stephane, Gorsh, Boris, Sapra, Sandhya, Loubert, Angély, Davis, Randy, Nelsen, Linda, Cardellino, Anna, Eliason, Laurie
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Exploring alternative dosing regimens of single-agent belantamab mafodotin on safety and efficacy in patients with relapsed or refractory multiple myeloma: DREAMM-14
Hultcrantz, Malin, Kleinman, David, Ghataorhe, Pavandeep, McKeown, Astrid, He, Wei, Ling, Thomas, Jewell, Roxanne C., Byrne, Julie, Eliason, Laurie, Scott, Emma Catherine, Opalinska, Joanna
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Patient-Reported Experiences during and Following Treatment with Belantamab Mafodotin (Belamaf) for Relapsed/Refractory Multiple Myeloma (RRMM) in the DREAMM-2 Study
Eliason, Laurie, Correll, Julia, Martin, Mona, Cardellino, Anna, Opalinska, Joanna, Piontek, Trisha, Gorsh, Boris, Sapra, Sandhya, Popat, Rakesh
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Lisocabtagene Maraleucel in Relapsed/Refractory Mantle Cell Lymphoma: Primary Analysis of the Mantle Cell Lymphoma Cohort From TRANSCEND NHL 001, a Phase I Multicenter Seamless Design Study
Wang, Michael, Siddiqi, Tanya, Gordon, Leo I, Kamdar, Manali, Lunning, Matthew, Hirayama, Alexandre V, Abramson, Jeremy S, Arnason, Jon, Ghosh, Nilanjan, Mehta, Amitkumar, Andreadis, Charalambos, Solomon, Scott R, Kostic, Ana, Dehner, Christine, Espinola, Ricardo, Peng, Lily, Ogasawara, Ken, Chattin, Amy, Eliason, Laurie, Palomba, M Lia
Published in Journal of clinical oncology (01.04.2024)
Published in Journal of clinical oncology (01.04.2024)
Get full text
Journal Article
Exploring Alternative Dosing Regimens of Single-Agent Belantamab Mafodotin on Safety and Efficacy in Patients with Relapsed or Refractory Multiple Myeloma: DREAMM-14
Hultcrantz, Malin, Kleinman, David, Ghataorhe, Pavandeep, McKeown, Astrid, He, Wei, Ling, Thomas, Jewell, Roxanne C, Brunner, Joseph, Byrne, Julie, Eliason, Laurie, Scott, Emma, Opalinska, Joanna
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
Health related quality of life (HRQoL) in patients with triple-class-exposed relapsed/refractory multiple myeloma (TCE RRMM) treated with idecabtagene vicleucel (ide-cel) versus standard regimens: Patient-reported outcomes (PROs) from KarMMa-3 phase 3 randomized controlled trial (RCT)
Delforge, Michel, Patel, Krina K., Eliason, Laurie, Dhanda, Devender, Shi, Ling, Guo, Shien, Marshall, Thomas, Arnulf, Bertrand, Cavo, Michele, Nooka, Ajay K., Manier, Salomon, Callander, Natalie Scott, Giralt, Sergio, Einsele, Hermann, Ailawadhi, Sikander, Popa McKiver, Mihaela, Cook, Mark, Rodríguez-Otero, Paula
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
386 Patient-reported outcomes (PROS) in the garnet trial in patients (PTS) with advanced or recurrent mismatch repair deficient/microsatelite instability-high (DMMR/MSI-H) endometrial cancer (EC) treated with dostarlimab
Kristeleit, Rebecca, Mathews, Cara, Redondo, Andrés, Huang, Joice, Eliason, Laurie, Im, Ellie, Brown, Jubilee
Published in International journal of gynecological cancer (01.12.2020)
Published in International journal of gynecological cancer (01.12.2020)
Get full text
Journal Article
Effects of Idecabtagene Vicleucel (Ide-Cel) Versus Standard Regimens on Health-Related Quality of Life (HRQoL) in Patients with Triple-Class-Exposed (TCE) Relapsed/Refractory Multiple Myeloma (RRMM) Who Received at Least 3 Lines of Prior Antimyeloma Regimens in the KarMMa-3 Phase 3 Randomized Controlled Trial
Delforge, Michel, Patel, Krina K., Eliason, Laurie, Dhanda, Devender, Shi, Ling, Guo, Shien, Marshall, Thomas S., Arnulf, Bertrand, Cavo, Michele, Nooka, Ajay K., Manier, Salomon, Callander, Natalie S., Giralt, Sergio A., Einsele, Hermann, Ailawadhi, Sikander, Popa-McKiver, Mihaela, Cook, Mark, Rodríguez Otero, Paula
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Efficacy and Safety of Idecabtagene Vicleucel (ide-cel) in Patients with Clinical High-Risk Newly Diagnosed Multiple Myeloma (NDMM) with an Inadequate Response to Frontline Autologous Stem Cell Transplantation (ASCT): KarMMa-2 Cohort 2c Extended Follow-up
Dhodapkar, Madhav V., Alsina, Melissa, Berdeja, Jesus G., Patel, Krina K., Richard, Shambavi, Vij, Ravi, Leleu, Xavier, Egan, Daniel N., Bergsagel, P. Leif, Reshef, Ran, Usmani, Saad Z, Truppel-Hartmann, Anna, Basudhar, Debashree, Thompson, Ethan, Zheng, Xirong, Eliason, Laurie, Zhong, Xiaobo, Greggio, Chiara, Tran, Sinhan, Chaudhry, Maria, Carrasco-Alfonso, Marlene J., Siegel, David S.
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article